Hepatitis C management by addiction medicine physicians: results from a national survey
about
Can antiviral treatment for hepatitis C be safely and effectively delivered in primary care?: a narrative systematic review of the evidence baseEligibility of persons who inject drugs for treatment of hepatitis C virus infection.Successful integration of hepatitis C evaluation and treatment services with methadone maintenance.Hepatitis infection in the treatment of opioid dependence and abuse.A pilot training program for a motivational enhancement approach to hepatitis C virus treatment among individuals in Israeli methadone treatment centers.Chronic hepatitis C: treat or wait? Medical decision making in clinical practiceBreaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV/HIV coinfection: action required at the system, provider, and patient levelsEvaluation of an integrated care service facility for people living with hepatitis C in New Zealand.Successful treatment of chronic hepatitis C with pegylated interferon in combination with ribavirin in a methadone maintenance treatment program.Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review.Hepatitis C virus control among persons who inject drugs requires overcoming barriers to care.Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers.Models of care for the management of hepatitis C virus among people who inject drugs: one size does not fit all.Desired social distance from people who have hepatitis C virus: an exploration among staff in health care, dentistry, drug treatment, and tattoo/body piercing.
P2860
Q27010015-851FC023-37A5-4621-9DBC-3A586BE13654Q30429470-00383E79-5CE6-4E9F-BE29-0CFC82CCA5CEQ33858467-E98BCE52-348A-4F1C-85BC-78D0B403F443Q35389163-34531EE2-441F-44A2-ADD0-8149C63A7DD8Q35834617-BC36539E-5183-486A-BB6A-CB73636CD794Q35872101-129FB6D3-1A5B-4C7F-9134-49603DA0D882Q36590782-C300C1F5-AE2E-4564-B67E-9B0A8AC13CCAQ36700770-459502CE-CA99-4AC8-94FD-F388802FCBB1Q37216987-E1FF0216-4B62-427C-8C76-23947C621BA8Q37245420-1E920375-07B9-49FF-946B-BB43150FCB9EQ37358615-704E63C6-5064-410E-8319-04FF0F615D23Q38064495-77FC1817-F2F5-4DC2-81E7-3DC91DCA7D6DQ38123945-3730EBF6-885B-4820-9309-C5C2E02F96A6Q42255890-05A7BC48-ADCA-4FAF-ACDD-8D39EE3B48FE
P2860
Hepatitis C management by addiction medicine physicians: results from a national survey
description
2007 nî lūn-bûn
@nan
2007 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մարտին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Hepatitis C management by addiction medicine physicians: results from a national survey
@ast
Hepatitis C management by addiction medicine physicians: results from a national survey
@en
Hepatitis C management by addiction medicine physicians: results from a national survey
@nl
type
label
Hepatitis C management by addiction medicine physicians: results from a national survey
@ast
Hepatitis C management by addiction medicine physicians: results from a national survey
@en
Hepatitis C management by addiction medicine physicians: results from a national survey
@nl
prefLabel
Hepatitis C management by addiction medicine physicians: results from a national survey
@ast
Hepatitis C management by addiction medicine physicians: results from a national survey
@en
Hepatitis C management by addiction medicine physicians: results from a national survey
@nl
P2093
P2860
P1476
Hepatitis C management by addiction medicine physicians: results from a national survey
@en
P2093
Alain H Litwin
Alex D Federman
Hillary V Kunins
Julia H Arnsten
Karina M Berg
Karyn K Heavner
P2860
P304
P356
10.1016/J.JSAT.2006.12.001
P577
2007-03-26T00:00:00Z